Invictus has developed two proprietary, patented and evidence-based nutraceutical products using its proprietary MELT3™ Delivery Platform for Nutraceuticals. Invictus plans to launch these products in the US market soon.

The two products are:

nE1-ElitE, which has single daily servings containing 40mgs of delta T3s as the key dietary ingredient and formulated as a flavoured powder packaged in a stick pack for easy storage and consumption. Designed to help achieve greater peak power during exercise, improve muscle recovery and reduce delayed onset muscle soreness (DOMS) after workout therefore making it more enjoyable to workout.

nE1-Heart, which has single daily servings containing 20mgs of delta T3s as the key dietary ingredient and formulated as a flavoured powder packaged in a stick pack for easy storage and consumption.  Designed to assist in the maintenance of of cholesterol already in the normal range and acts as a powerful antioxidant.

Please note that both nE1-Elite and nE1-Heart are prototype products for the US only and are not for sale outside of the US

The use of the MELT3™ platform in nE1-ElitE™ has been shown in clinical studies to be effective for the reduction of DOMS, improvement of muscle recovery after exercise and maintenance of peak muscle power. This platform, which in its present form, comprises a powder which is dissolved in the mouth and then swallowed, will initially underpin all of Invictus’ nutraceutical products.  

For nE1-Heart™, clinical data from a substantial body of peer-reviewed scientific articles support the fact that T3s may be useful in the maintenance of cholesterol already in the normal range and acts as a powerful antioxidant in the body.  T3s also have a similarity to the Gold Standard drug for hyperlipidaemia, statins, in that they inhibit the biosynthesis of cholesterol by blocking the HMCG CoA pathway.

TOP